Efficacy of angiotensin receptor neprilysin inhibitor in Asian patients with refractory hypertension

Efficacy of angiotensin receptor neprilysin inhibitor in Asian patients with refractory hypertension

Abstract Sacubitril/valsartan, simultaneously inhibits neprilysin and angiotensin II receptor, showed an effect in reducing blood pressure (BP). The authors aimed to study whether it can be used as an antihypertensive agent in patients with refractory hypertension who have already been treated. A to...

Full description

Bibliographic Details
Main Authors: Wanjing Li, Minghui Gong, Qin Yu, Rihui Liu, Kaiming Chen, Wei Lv, Fumei Yao, Zhaolong Xu, Yi Xu, Wei Song, Yinong Jiang
Format: Article
Language:English
Published: Wiley 2022-04-01
Series:The Journal of Clinical Hypertension
Subjects:
ambulatory blood pressure monitoring
angiotensin receptor neprilysin inhibitor
Asia
refractory hypertension
sacubitril/valsartan
Online Access:https://doi.org/10.1111/jch.14454

Internet

https://doi.org/10.1111/jch.14454

Similar Items